These findings are consistent with other studies in CRC showing that LIMK1 mRNA and protein levels were associated with poor prognosis, including depth of invasion, lymph node metastasis, tumor stage, distal metastases, and reduced survival rate [19, 31, 32]. Here, LIMK1 is linked to neoplasm.